Regarding the lipid profile, a greater proportion of cases with dyslipidemia was detected among the (+) anti-β2AR Abs patients (51.7% vs. 12.5%; p = 0.004) with predominance of hypertriglyceridemia (58.9 vs. 33.3%; p = 0.035). The gene discussed is ADRB2; the disease is metabolic syndrome.